Skip to Main content Skip to Navigation
Journal articles

Antiviral therapy of chronic hepatitis B.

Fabien Zoulim 1, * 
Abstract : Treatment of chronic hepatitis B remains a clinical challenge. Long-term viral suppression is a major goal of antiviral therapy to improve the clinical outcome of the patients. Antiviral treatment of chronic hepatitis B relies currently on immune modulators such as interferon alpha and its pegylated form, and viral polymerase inhibitors. Because of the slow kinetics of viral clearance and the spontaneous viral genome variability, viral mutants resistant to nucleoside analogs may be selected. However, the development of new antiviral agents is rapidly improving the offing of therapy of chronic hepatitis B. These new therapeutic advances are reviewed in this manuscript.
Complete list of metadata

Cited literature [78 references]  Display  Hide  Download
Contributor : Fabien Zoulim Connect in order to contact the contributor
Submitted on : Friday, March 2, 2007 - 5:05:23 PM
Last modification on : Friday, October 23, 2020 - 4:42:21 PM
Long-term archiving on: : Tuesday, April 6, 2010 - 11:09:50 PM




Fabien Zoulim. Antiviral therapy of chronic hepatitis B.. Antiviral Research, Elsevier Masson, 2006, 71 (2-3), pp.206-15. ⟨10.1016/j.antiviral.2006.04.003⟩. ⟨inserm-00134589⟩



Record views


Files downloads